CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MIELT1D project investigates the genetic factors contributing to Type 1 diabetes (T1D) susceptibility, focusing on the role of beta-2 microglobulin and MHC class I in T cell development. The goal is to identify at-risk individuals for early intervention and develop immunomodulatory therapies to prevent disease prog…
Type 1 diabetes (T1D) results from autoimmune attack of the insulin-producing beta cells, and consequently glucose can no longer be absorbed and utilized by the body.
Although patients receive insulin injections to help regulate blood glucose, the regulation achieved is far from ideal and patients develop long-term complications.
Current strategies to prevent T1D involve developing immunomodulatory therapies to arrest or slow disease progression of the autoimmune process.
It is likely such immun…
UNIVERSITE DE LA MEDITERRANEE D'AIX-MARSEILLE II
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
